Reported benefits (per available research): Studied for restoring more youthful pulsatile GH and IGF-1 secretion in older adults, based on a small 1997 randomized, placebo-controlled human trial of a closely related GHRH(1-29) analog published in the Journal of Clinical Endocrinology & Metabolism May support gains in lean body mass in men specifically: that same 16-week trial found a statistically significant increase in lean body mass in men but not in women, alongside a significant increase in skin thickness (a marker of dermal collagen) in both sexes Proposed to support broader recovery and body-composition goals tied to growth-hormone-axis activity, though sermorelin-specific modern adult trial data remains thin, and much of the anti-aging and muscle-building framing used in commercial marketing outpaces the current clinical evidence base Known risks and side effects: Injection-site reactions (pain, swelling, or redness) are the most commonly reported adverse event associated with sermorelin therapy in manufacturer drug-labeling data Headache, flushing, dizziness, difficulty swallowing, hyperactivity, drowsiness, and hives have also been reported less commonly per that same labeling data
Table 1 Study participants demographics, anthropometric characteristics, and baseline circulatory (serum) vitamin B12 levels
Benefits: Promotes cardiovascular health and recovery Enhances circulation Supports heart cell energy and protection BDNF (Brain-Derived Neurotrophic Factor) Purpose: A neuro-peptide promoting brain cell regeneration and cognitive function
SAXS (Small-Angle X-ray Scattering): SAXS is used to determine the average particle size, shape, distribution, and surface-to-volume ratio by analyzing the elastic scattering of X-rays at small angles when passed through a specimen
However, the main concern with oral delivery is bioavailability, or how much of the peptide is absorbed into the bloodstream after digestion
10.3899/jrheum.110277
